Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Prepaid Assets (2016 - 2025)

Catalyst Pharmaceuticals' Prepaid Assets history spans 16 years, with the latest figure at $5.9 million for Q4 2025.

  • For Q4 2025, Prepaid Assets fell 25.67% year-over-year to $5.9 million; the TTM value through Dec 2025 reached $5.9 million, down 25.67%, while the annual FY2025 figure was $5.9 million, 25.67% down from the prior year.
  • Prepaid Assets reached $5.9 million in Q4 2025 per CPRX's latest filing, down from $10.6 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $14.0 million in Q3 2023 to a low of $351000.0 in Q4 2023.
  • Average Prepaid Assets over 5 years is $5.8 million, with a median of $5.1 million recorded in 2022.
  • The largest YoY upside for Prepaid Assets was 2167.52% in 2024 against a maximum downside of 96.35% in 2024.
  • A 5-year view of Prepaid Assets shows it stood at $4.4 million in 2021, then rose by 18.75% to $5.2 million in 2022, then plummeted by 93.21% to $351000.0 in 2023, then soared by 2167.52% to $8.0 million in 2024, then dropped by 25.67% to $5.9 million in 2025.
  • Per Business Quant, the three most recent readings for CPRX's Prepaid Assets are $5.9 million (Q4 2025), $10.6 million (Q3 2025), and $1.2 million (Q2 2025).